Evaluation of the analytical and clinical concordance of 25-hydroxyvitamin d levels in dried blood spots, dried serum spots, and serum as potential biorepository specimens

Gellert Karvaly, Györgyi Molnár-Világos, Krisztián Kovács, Katalin Mészáros, A. Patócs, B. Vásárhelyi

Research output: Contribution to journalArticle

Abstract

Context: The promising perspective of storing dried blood spot (DBS) for evaluating 25-hydroxyvitamin D (25OHD) levels is increasingly being realized. While strong correlations have been demonstrated between 25OHD levels measured in DBS and in systemic serum samples in earlier works, the clinical concordance of the assay results has not been evaluated. Moreover, the utility of dried serum spot (DSS), a highly suitable matrix for sample archiving, has not been investigated in this respect. Methods: 25-hydroxycholecalciferol and 25-hydroxyergocalciferol levels were established selectively in DBS (n = 73) and DSS (n = 67) specimens obtained from deidentified whole blood and serum using a previously validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. In addition, total 25OHD levels were determined in the serum samples using the LIAISON 25OH Total Vitamin D Assay (LIA, n = 73). The analytical and clinical performance of the three approaches was compared pairwise. Results: Deming regression, Bland-Altman analysis, and concordance correlation coefficients consistently demonstrated the lack of analytical equivalence among the three result sets. The overall percentage agreement of the clinical classifications (hypovitaminosis or euvitaminosis) was moderate (67.1%-83.6%). The delivery of positive cases was decreasing significantly in the order LIA>DSS>DBS (p < 0.05). Conclusions: The approaches tested did not deliver equivalent outputs either in an analytical or a clinical context. Therefore, specific reference ranges must be established for each matrix to avoid false clinical evaluation. 25OHD can be quantified when assay results are scaled by a factor of 1.60-1.67. Considering the convenience and efficiency of the storage and processing of DSS, along with the difficulties of quantifying 25OHD in real-life DBS samples accurately, DSS is proposed as an alternative for the long-term archiving of specimens.

Original languageEnglish
Pages (from-to)285-292
Number of pages8
JournalBiopreservation and Biobanking
Volume15
Issue number4
DOIs
Publication statusPublished - Aug 1 2017

Fingerprint

Blood
Serum
Assays
25-Hydroxyvitamin D 2
Calcifediol
Liquid chromatography
Vitamin D
Mass spectrometry
Tandem Mass Spectrometry
Liquid Chromatography
Reference Values
Processing

Keywords

  • clinical concordance
  • dried blood spot
  • dried serum spot
  • Vitamin D

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Cell Biology

Cite this

Evaluation of the analytical and clinical concordance of 25-hydroxyvitamin d levels in dried blood spots, dried serum spots, and serum as potential biorepository specimens. / Karvaly, Gellert; Molnár-Világos, Györgyi; Kovács, Krisztián; Mészáros, Katalin; Patócs, A.; Vásárhelyi, B.

In: Biopreservation and Biobanking, Vol. 15, No. 4, 01.08.2017, p. 285-292.

Research output: Contribution to journalArticle

@article{d7caed985bbf40cda7a0cfa01d00ebed,
title = "Evaluation of the analytical and clinical concordance of 25-hydroxyvitamin d levels in dried blood spots, dried serum spots, and serum as potential biorepository specimens",
abstract = "Context: The promising perspective of storing dried blood spot (DBS) for evaluating 25-hydroxyvitamin D (25OHD) levels is increasingly being realized. While strong correlations have been demonstrated between 25OHD levels measured in DBS and in systemic serum samples in earlier works, the clinical concordance of the assay results has not been evaluated. Moreover, the utility of dried serum spot (DSS), a highly suitable matrix for sample archiving, has not been investigated in this respect. Methods: 25-hydroxycholecalciferol and 25-hydroxyergocalciferol levels were established selectively in DBS (n = 73) and DSS (n = 67) specimens obtained from deidentified whole blood and serum using a previously validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. In addition, total 25OHD levels were determined in the serum samples using the LIAISON 25OH Total Vitamin D Assay (LIA, n = 73). The analytical and clinical performance of the three approaches was compared pairwise. Results: Deming regression, Bland-Altman analysis, and concordance correlation coefficients consistently demonstrated the lack of analytical equivalence among the three result sets. The overall percentage agreement of the clinical classifications (hypovitaminosis or euvitaminosis) was moderate (67.1{\%}-83.6{\%}). The delivery of positive cases was decreasing significantly in the order LIA>DSS>DBS (p < 0.05). Conclusions: The approaches tested did not deliver equivalent outputs either in an analytical or a clinical context. Therefore, specific reference ranges must be established for each matrix to avoid false clinical evaluation. 25OHD can be quantified when assay results are scaled by a factor of 1.60-1.67. Considering the convenience and efficiency of the storage and processing of DSS, along with the difficulties of quantifying 25OHD in real-life DBS samples accurately, DSS is proposed as an alternative for the long-term archiving of specimens.",
keywords = "clinical concordance, dried blood spot, dried serum spot, Vitamin D",
author = "Gellert Karvaly and Gy{\"o}rgyi Moln{\'a}r-Vil{\'a}gos and Kriszti{\'a}n Kov{\'a}cs and Katalin M{\'e}sz{\'a}ros and A. Pat{\'o}cs and B. V{\'a}s{\'a}rhelyi",
year = "2017",
month = "8",
day = "1",
doi = "10.1089/bio.2016.0082",
language = "English",
volume = "15",
pages = "285--292",
journal = "Biopreservation and Biobanking",
issn = "1947-5535",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Evaluation of the analytical and clinical concordance of 25-hydroxyvitamin d levels in dried blood spots, dried serum spots, and serum as potential biorepository specimens

AU - Karvaly, Gellert

AU - Molnár-Világos, Györgyi

AU - Kovács, Krisztián

AU - Mészáros, Katalin

AU - Patócs, A.

AU - Vásárhelyi, B.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Context: The promising perspective of storing dried blood spot (DBS) for evaluating 25-hydroxyvitamin D (25OHD) levels is increasingly being realized. While strong correlations have been demonstrated between 25OHD levels measured in DBS and in systemic serum samples in earlier works, the clinical concordance of the assay results has not been evaluated. Moreover, the utility of dried serum spot (DSS), a highly suitable matrix for sample archiving, has not been investigated in this respect. Methods: 25-hydroxycholecalciferol and 25-hydroxyergocalciferol levels were established selectively in DBS (n = 73) and DSS (n = 67) specimens obtained from deidentified whole blood and serum using a previously validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. In addition, total 25OHD levels were determined in the serum samples using the LIAISON 25OH Total Vitamin D Assay (LIA, n = 73). The analytical and clinical performance of the three approaches was compared pairwise. Results: Deming regression, Bland-Altman analysis, and concordance correlation coefficients consistently demonstrated the lack of analytical equivalence among the three result sets. The overall percentage agreement of the clinical classifications (hypovitaminosis or euvitaminosis) was moderate (67.1%-83.6%). The delivery of positive cases was decreasing significantly in the order LIA>DSS>DBS (p < 0.05). Conclusions: The approaches tested did not deliver equivalent outputs either in an analytical or a clinical context. Therefore, specific reference ranges must be established for each matrix to avoid false clinical evaluation. 25OHD can be quantified when assay results are scaled by a factor of 1.60-1.67. Considering the convenience and efficiency of the storage and processing of DSS, along with the difficulties of quantifying 25OHD in real-life DBS samples accurately, DSS is proposed as an alternative for the long-term archiving of specimens.

AB - Context: The promising perspective of storing dried blood spot (DBS) for evaluating 25-hydroxyvitamin D (25OHD) levels is increasingly being realized. While strong correlations have been demonstrated between 25OHD levels measured in DBS and in systemic serum samples in earlier works, the clinical concordance of the assay results has not been evaluated. Moreover, the utility of dried serum spot (DSS), a highly suitable matrix for sample archiving, has not been investigated in this respect. Methods: 25-hydroxycholecalciferol and 25-hydroxyergocalciferol levels were established selectively in DBS (n = 73) and DSS (n = 67) specimens obtained from deidentified whole blood and serum using a previously validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. In addition, total 25OHD levels were determined in the serum samples using the LIAISON 25OH Total Vitamin D Assay (LIA, n = 73). The analytical and clinical performance of the three approaches was compared pairwise. Results: Deming regression, Bland-Altman analysis, and concordance correlation coefficients consistently demonstrated the lack of analytical equivalence among the three result sets. The overall percentage agreement of the clinical classifications (hypovitaminosis or euvitaminosis) was moderate (67.1%-83.6%). The delivery of positive cases was decreasing significantly in the order LIA>DSS>DBS (p < 0.05). Conclusions: The approaches tested did not deliver equivalent outputs either in an analytical or a clinical context. Therefore, specific reference ranges must be established for each matrix to avoid false clinical evaluation. 25OHD can be quantified when assay results are scaled by a factor of 1.60-1.67. Considering the convenience and efficiency of the storage and processing of DSS, along with the difficulties of quantifying 25OHD in real-life DBS samples accurately, DSS is proposed as an alternative for the long-term archiving of specimens.

KW - clinical concordance

KW - dried blood spot

KW - dried serum spot

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=85027221389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027221389&partnerID=8YFLogxK

U2 - 10.1089/bio.2016.0082

DO - 10.1089/bio.2016.0082

M3 - Article

VL - 15

SP - 285

EP - 292

JO - Biopreservation and Biobanking

JF - Biopreservation and Biobanking

SN - 1947-5535

IS - 4

ER -